宫颈癌患者血清胸苷激酶、CA125的表达及临床意义(1)
 |
| 第1页 |
参见附件。
[摘要] 目的 探讨宫颈癌患者TK1及CA125对其诊断及治疗中的意义。方法 联合检测50例宫颈癌患者、30例同期进行体检的健康妇女血清中TK1、CA125的含量，同时对宫颈癌患者在同期放化疗后再次测定TK1、CA125的含量并与治疗前进行比较。结果 宫颈癌患者的TK1、CA125含量显著高于对照组(P<0.001)，治疗后宫颈癌患者的TK1、CA125较治疗前显著下降(P<0.05)。结论 TK1、CA125的水平在宫颈癌的诊断、治疗及预后评估中有一定的价值。
[关键词] 宫颈癌；胸苷激酶1；肿瘤抗原1251
[中图分类号] R737 [文献标识码] A [文章编号] 1674-0742(2014)11(c)-0023-02
[Abstract] Objective To investigate the value of serum thymidine kinase 1 (TK1) and cancer antigen 125(CA125) in the diagnosis and treatment of cervical cancer. Methods The combined detection of the content of serum TK1 and CA125 was performed in 50 cases with cervical cancer (the cervical cancer group) and 30 healthy controls (the control group) underwent physical examination over the same period ......
您现在查看是摘要介绍页，详见PDF附件。